Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Opthea ( (AU:OPT) ) has shared an announcement.
Opthea Limited announced the successful passage of all resolutions at its Annual General Meeting, reflecting strong shareholder support. The resolutions included the re-election of directors and the issuance of options under various plans, which are crucial for the company’s governance and strategic incentive structures.
The most recent analyst rating on (AU:OPT) stock is a Sell with a A$0.05 price target. To see the full list of analyst forecasts on Opthea stock, see the AU:OPT Stock Forecast page.
More about Opthea
Opthea Limited is a biotechnology company focused on developing therapies for eye diseases. The company is listed on both the Australian Securities Exchange (ASX) and NASDAQ, indicating its active participation in the global market.
Technical Sentiment Signal: Sell
Current Market Cap: A$738.8M
For an in-depth examination of OPT stock, go to TipRanks’ Overview page.